Overview

Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to see how a dietary oil called conjugated linoleic acid, or CLA, might be useful in combination with diabetes medication. Some studies show that CLA can modestly reduce body weight and body fat. Our research idea is that taking CLA will reduce body weight and body fat without interfering with the diabetes medications' effects on blood sugar.
Phase:
Phase 1
Details
Lead Sponsor:
Ohio State University
Collaborators:
Bunge Loders Croklaan
GlaxoSmithKline
LifeScan
Loders Croklaan
National Center for Complementary and Integrative Health (NCCIH)
Treatments:
Rosiglitazone